Showing results (81-90 of 297) with videos related to
Sort By:
Pageof 30
Clinical and Experimental Rheumatology|January 28, 2021
Impact and applicability of pharmacogenomics in rheumatology: an integrated analysisPankti Reid, Keith Danahey, Marco Lopez Velazquez, et al.Journal of Clinical Microbiology|June 5, 2020
Newly Named Klebsiella aerogenes (formerly Enterobacter aerogenes) Is Associated with Poor Clinical Outcomes Relative to Other Enterobacter Species in Patients with Bloodstream InfectionAustin Wesevich, Granger Sutton, Felicia Ruffin, et al.JCO Oncology Practice|June 30, 2025
Longitudinal Associations Between Financial Toxicity and Health-Related Quality of Life for Patients With CancerAustin Wesevich, Rahul Dadwani, Donald Hedeker, et al.Pharmacogenomics|July 17, 2009
Pharmacodynamic genes do not influence risk of neutropenia in cancer patients treated with moderately high-dose irinotecanJanelle M Hoskins, Gary L Rosner, Mark J Ratain, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2003
Interethnic difference in the allelic distribution of human epidermal growth factor receptor intron 1 polymorphismWanqing Liu, Federico Innocenti, Peixian Chen, et al.Pharmacogenetics and Genomics|May 3, 2005
Haplotypes of variants in the UDP-glucuronosyltransferase1A9 and 1A1 genesFederico Innocenti, Wanqing Liu, Peixian Chen, et al.Investigational New Drugs|January 7, 2004
Subcutaneously administered recombinant human interleukin-2 and interferon alfa-2a for advanced breast cancer: a phase II study of the Cancer and Leukemia Group B (CALGB 9041)Gretchen Kimmick, Mark J Ratain, Don Berry, et al.Nature Reviews. Genetics|December 1, 2010
Pharmacogenomics: will the promise be fulfilled?Russ B Altman, Heyo K Kroemer, Catherine A McCarty, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Dose-escalating study of capecitabine plus gemcitabine combination therapy in patients with advanced cancerRichard L Schilsky, Donna Bertucci, Nicholas J Vogelzang, et al.European Journal of Cancer (Oxford, England : 1990)|May 26, 2009
R(+)XK469 inhibits hydroxylation of S-warfarin by CYP2C9Wei Peng Yong, Tae Won Kim, Samir D Undevia, et al.Pageof 30